Palliative care for patients with end-stage liver disease ineligible for liver transplantation

Gastroenterology Clinics of North America

Volumn 35, Issue 1, 2006, Pages 201-219

  Sanchez, William ^a   Talwalkar, Jayant A ^b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEOMYCIN;

ASCITES; CACHEXIA; DISEASE SEVERITY; HEPATIC ENCEPHALOPATHY; HEPATITIS C; HOSPICE; HUMAN; HYDROTHORAX; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TRANSPLANTATION; MUSCLE ATROPHY; NEPHROTOXICITY; PALLIATIVE THERAPY; PRURITUS; QUALITY OF LIFE; REVIEW; SURVIVAL; THORAX DRAINAGE;

HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; PALLIATIVE CARE; PATIENT SELECTION; PROGNOSIS;

EID: 33644829900     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2005.12.007     Document Type: Review

References (103)

1. M. Zoli, M.R. Cordiani, and G. Marchesini Prognostic indicators in compensated cirrhosis Am J Gastroenterol 86 1991 1508 1513
2. G. Fattovich, G. Giustina, and F. Degos Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Gastroenterology 112 1997 463 472
3. P. Gentilini, G. Laffi, and G. La Villa Long course and prognostic factors of virus-induced cirrhosis of the liver Am J Gastroenterol 92 1997 66 72
4. P. Gines, E. Quintero, and V. Arroyo Compensated cirrhosis: natural history and prognostic factors Hepatology 7 1987 122 128
5. M. Hashizume, K. Inokuchi, and K. Beppu The natural history of non-alcoholic cirrhosis Gastroenterol Jpn 19 1984 430 435
6. K.Q. Hu, and M.J. Tong The long-term outcomes of patients with compensated hepatitis C virus-related cirrhosis and history of parenteral exposure in the United States Hepatology 29 1999 1311 1316
7. I. Okazaki, K. Maruyama, and K. Funatsu Ten year survival rate of 131 patients with liver cirrhosis excluded the association of liver carcinoma at the establishment of diagnosis Gastroenterol Jpn 15 1980 350 354
8. G. Realdi, G. Fattovich, and S. Hadziyannis Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study. The Investigators of the European Concerted Action on Viral Hepatitis (EUROHEP) J Hepatol 21 1994 656 666
9. L. Serfaty, H. Aumaitre, and O. Chazouilleres Determinants of outcome of compensated hepatitis C virus-related cirrhosis Hepatology 27 1998 1435 1440
10. T. Sugimura, Y. Tsuji, and M. Sakamoto Long-term prognosis and prognostic factors of liver cirrhosis in the 1980s J Gastroenterol Hepatol 9 1994 154 161
11. R. Tanaka, T. Itoshima, and H. Nagashima Follow-up study of 582 liver cirrhosis patients for 26 years in Japan Liver 7 1987 316 324
12. G. D'Amico, A. Morabito, L. Pagliaro, and E. Marubini Survival and prognostic indicators in compensated and decompensated cirrhosis Dig Dis Sci 31 1986 468 475
13. D.L. Hoyert, H.C. Kung, and B.L. Smith Deaths: preliminary data for 2003 Natl Vital Stat Rep 53 2005 1 48
14. J. Bustamante, A. Rimola, and P.J. Ventura Prognostic significance of hepatic encephalopathy in patients with cirrhosis J Hepatol 30 1999 890 895
15. E. Christensen, J.J. Krintel, and S.M. Hansen Prognosis after the first episode of gastrointestinal bleeding or coma in cirrhosis: survival and prognostic factors Scand J Gastroenterol 24 1989 999 1006
16. G. Fernandez-Esparrach, A. Sanchez-Fueyo, and P. Gines A prognostic model for predicting survival in cirrhosis with ascites J Hepatol 34 2001 46 52
17. J. Llach, P. Gines, and V. Arroyo Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites Gastroenterology 94 1988 482 487
18. N. Magliocchetti, P. Torchio, and G. Corrao Prognostic factors for long-term survival in cirrhotic patients after the first episode of liver decompensation Ital J Gastroenterol Hepatol 29 1997 38 46
19. F. Salerno, G. Borroni, and P. Moser Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients Am J Gastroenterol 88 1993 514 519
20. R.L. Carithers Jr. Liver transplantation. American Association for the Study of Liver Diseases Liver Transpl 6 2000 122 135
21. 2004 Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003. Rockville (MD): Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; Richmond (VA): United Network for Organ Sharing; Ann Arbor (MI): University Renal Research and Education Association; 2004.
22. J.B. Saunders, J.R. Walters, A.P. Davies, and A. Paton A 20-year prospective study of cirrhosis BMJ (Clin Res Ed) 282 1981 263 266
23. N. Carbonell, A. Pauwels, and L. Serfaty Improved survival after variceal bleeding in patients with cirrhosis over the past two decades Hepatology 40 2004 652 659
24. A.J. Sanyal, C. Genning, and K.R. Reddy The North American Study for the Treatment of Refractory Ascites Gastroenterology 124 2003 634 641
25. C.I. Child, and J. Turcotte Surgery and portal hypertension C.I. Child The liver and portal hypertension 1964 Saunders Philadelphia 49 64
26. R.N. Pugh, I.M. Murray-Lyon, and J.L. Dawson Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 1973 646 649
27. E. Christensen, P. Schlichting, and L. Fauerholdt Prognostic value of Child-Turcotte criteria in medically treated cirrhosis Hepatology 4 1984 430 435
28. P.S. Kamath, R.H. Wiesner, and M. Malinchoc A model to predict survival in patients with end-stage liver disease Hepatology 33 2001 464 470
29. R.B. Freeman, R.H. Wiesner, and E. Edwards Results of the first year of the new liver allocation plan Liver Transpl 10 2004 7 15
30. R.H. Wiesner, S.V. McDiarmid, and P.S. Kamath MELD and PELD: application of survival models to liver allocation Liver Transpl 7 2001 567 580
31. M. Malinchoc, P.S. Kamath, and F.D. Gordon A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts Hepatology 31 2000 864 871
32. National Consensus Project for Quality Palliative Care. Clinical practice guidelines for quality palliative care. Available at: http://www.aahpm.org/ positions. Accessed April 1, 2005.
33. P.J. Hauptman, and E.P. Havranek Integrating palliative care into heart failure care Arch Intern Med 165 2005 374 378
34. WHO definition of palliative care. Available at: http://www.who.int/ cancer/palliative/definition/en. Accessed April 1, 2005.
35. Medical guidelines for determining prognosis in selected non-cancer diagnoses 1996 National Hospice and Palliative Care Organization Arlington (VA)
36. E. Fox, K. Landrum-McNiff, and Z. Zhong Evaluation of prognostic criteria for determining hospice eligibility in patients with advanced lung, heart, or liver disease. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments JAMA 282 1999 1638 1645
37. D.L. Patrick, J.R. Curtis, and R.A. Engelberg Measuring and improving the quality of dying and death Ann Intern Med 139 5 Pt 2 2003 410 415
38. N. Freeborne, J. Lynn, and N.A. Desbiens Insights about dying from the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments J Am Geriatr Soc 48 5 suppl 2000 S199 S205
39. M.H. Lin, P.Y. Wu, and S.T. Tsai Hospice palliative care for patients with hepatocellular carcinoma in Taiwan Palliat Med 18 2004 93 99
40. R.M. Wachter, J.M. Luce, N. Hearst, and B. Lo Decisions about resuscitation: inequities among patients with different diseases but similar prognoses Ann Intern Med 111 1989 525 532
41. S.Z. Pantilat Care of dying patients: beyond symptom management West J Med 171 1999 253 256
42. B.A. Runyon Management of adult patients with ascites caused by cirrhosis Hepatology 27 1998 264 272
43. T.B. Reynolds, H.M. Geller, O.T. Kuzma, and A.G. Redeker Spontaneous decrease in portal pressure with clinical improvement in cirrhosis N Engl J Med 263 1960 734 739
44. M.R. Fogel, V.K. Sawhney, and E.A. Neal Diuresis in the ascitic patient: a randomized controlled trial of three regimens J Clin Gastroenterol 3 Suppl 1 1981 73 80
45. R.M. Perez-Ayuso, V. Arroyo, and R. Planas Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites: relationship between the diuretic response and the activity of the renin-aldosterone system Gastroenterology 84 5 Pt 1 1983 961 968
46. J. Sola-Vera, J. Minana, and E. Ricart Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites Hepatology 37 2003 1147 1153
47. O. Riggio, M. Merlli, and G. Pedretti Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: incidence and risk factors Dig Dis Sci 41 1996 578 584
48. A.J. Sanyal, A.M. Freedman, and M.L. Shiffman Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study Hepatology 20 1 Pt 1 1994 46 55
49. A.J. Sanyal, A.M. Freedman, and V.A. Luketic Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: a randomized, controlled trial Ann Intern Med 126 1997 849 857
50. B. Rosado, and P.S. Kamath Transjugular intrahepatic portosystemic shunts: an update Liver Transpl 9 2003 207 217
51. K.A. Somberg, J.L. Riegler, and J.M. LaBerge Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors Am J Gastroenterol 90 1995 549 555
52. A.J. Sanyal, A.M. Freedman, and V.A. Luketic The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts Gastroenterology 112 1997 889 898
53. P.S. Kamath, and M.A. McKusick Transvenous intrahepatic portosystemic shunts Gastroenterology 111 1996 1700 1705
54. M. Casado, J. Bosch, and J.C. Garcia-Pagan Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings Gastroenterology 114 1998 1296 1303
55. M.M. Stanley, S. Ochi, and K.K. Lee Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Administration Cooperative Study on Treatment of Alcoholic Cirrhosis with Ascites N Engl J Med 321 1989 1632 1638
56. P. Bories, D. Garcia Compean, and H. Michel The treatment of refractory ascites by the LeVeen shunt: a multi-centre controlled trial (57 patients) J Hepatol 3 1986 212 218
57. E.E. Zervos, J. McCormick, S.E. Goode, and A.S. Rosemurgy Peritoneovenous shunts in patients with intractable ascites: palliation at what price? Am Surg 63 1997 157 162
58. G.M. Reisfield, and G.R. Wilson Management of intractable, cirrhotic ascites with an indwelling drainage catheter J Palliat Med 6 2003 787 791
59. H.M. Richard 3rd, D.M. Coldwell, and R.L. Boyd-Kranis Pleurx tunneled catheter in the management of malignant ascites J Vasc Interv Radiol 12 2001 373 375
60. T.D. Iyengar, and T.J. Herzog Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter Am J Hosp Palliat Care 19 2002 35 38
61. L.U. Liu, H.A. Haddadin, and C.A. Bodian Outcome analysis of cirrhotic patients undergoing chest tube placement Chest 126 2004 142 148
62. K.N. Lazaridis, J.W. Frank, M.J. Krowka, and P.S. Kamath Hepatic hydrothorax: pathogenesis, diagnosis, and management Am J Med 107 1999 262 267
63. V. Siegerstetter, P. Deibert, and A. Ochs Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients Eur J Gastroenterol Hepatol 13 2001 529 534
64. F.D. Gordon, H.T. Anastopoulos, and W. Crenshaw The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt Hepatology 25 1997 1366 1369
65. M.R. Arguedas, T.G. DeLawrence, and B.M. McGuire Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis Dig Dis Sci 48 2003 1622 1626
66. A. Das, R.K. Dhiman, and V.A. Saraswat Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis J Gastroenterol Hepatol 16 2001 531 535
67. S.M. Riordan, and R. Williams Treatment of hepatic encephalopathy N Engl J Med 337 1997 473 479
68. P. Ferenci, A. Lockwood, and K. Mullen Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology,Vienna,1998 Hepatology 35 2002 716 721
69. A.T. Blei, and J. Cordoba Practice Parameters Committee of the American College of Gastroenterology Hepatic Encephalopathy Am J Gastroenterol 96 2001 1968 1976
70. A. Mas, J. Rodes, and L. Sunyer Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial J Hepatol 38 1 2003 51 58
71. M. Mela, A. Mancuso, and A.K. Burroughs Review article: pruritus in cholestatic and other liver diseases Aliment Pharmacol Ther 17 2003 857 870
72. D.V. Datta, and S. Sherlock Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis Gastroenterology 50 1966 323 332
73. N.B. Javitt Timing of cholestyramine doses in cholestatic liver disease N Engl J Med 290 1974 1328 1329 [letter]
74. J.P. Miguet, P. Mavier, C.J. Soussy, and D. Dhumeaux Induction of hepatic microsomal enzymes after brief administration of rifampicin in man Gastroenterology 72 5 Pt 1 1977 924 926
75. A. Podesta, P. Lopez, and R. Terg Treatment of pruritus of primary biliary cirrhosis with rifampin Dig Dis Sci 36 1991 216 220
76. C.N. Ghent, and S.G. Carruthers Treatment of pruritus in primary biliary cirrhosis with rifampin: results of a double-blind, crossover, randomized trial Gastroenterology 94 1988 488 493
77. N.V. Bergasa, D.W. Alling, and T.L. Talbot Effects of naloxone infusions in patients with the pruritus of cholestasis: a double-blind, randomized, controlled trial Ann Intern Med 123 1995 161 167
78. N.V. Bergasa, J.M. Schmitt, and T.L. Talbot Open-label trial of oral nalmefene therapy for the pruritus of cholestasis Hepatology 27 1998 679 684
79. R. Terg, E. Coronel, and J. Sorda Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study J Hepatol 37 2002 717 722
80. J.R. Thornton, and M.S. Losowsky Opioid peptides and primary biliary cirrhosis BMJ 297 1988 1501 1504
81. F.H. Wolfhagen, E. Sternieri, and W.C. Hop Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study Gastroenterology 113 1997 1264 1269
82. J. Browning, B. Combes, and M.J. Mayo Long-term efficacy of sertraline as a treatment for cholestatic pruritus in patients with primary biliary cirrhosis Am J Gastroenterol 98 2003 2736 2741
83. H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
84. H.B. El-Serag, J.A. Davila, N.J. Petersen, and K.A. McGlynn The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 2003 817 823
85. J.M. Llovet, J. Fuster, and J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1999 1434 1440
86. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
87. H. Ishii, S. Okada, and H. Nose Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection Cancer 77 1996 1792 1796
88. R. Tateishi, S. Shiina, and T. Teratani Percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1000 cases Cancer 103 2005 1201 1209
89. S.M. Lin, C.J. Lin, and C.C. Lin Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm Gastroenterology 127 2004 1714 1723
90. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
91. Z. Hassoun, and G.J. Gores Treatment of hepatocellular carcinoma Clin Gastroenterol Hepatol 1 2003 10 18
92. Y.Z. Patt, M.M. Hassan, and R.D. Lozano Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial Cancer 103 2005 749 755
93. T.E. Wang, C.R. Kao, and S.C. Lin Salvage therapy for hepatocellular carcinoma with thalidomide World J Gastroenterol 10 2004 649 653
94. N. Singh, T. Gayowski, M.M. Wagener, and I.R. Marino Depression in patients with cirrhosis: impact on outcome Dig Dis Sci 42 1997 1421 1427
95. J. Cordoba, J. Cabrera, and L. Lataif High prevalence of sleep disturbance in cirrhosis Hepatology 27 1998 339
96. J. Goldblatt, P.J. Taylor, and T. Lipman The true impact of fatigue in primary biliary cirrhosis: a population study Gastroenterology 122 2002 1235
97. D. Sene, N. Limal, and P. Cacoub Hepatitis C virus-associated extrahepatic manifestations: a review Metab Brain Dis 19 2004 357
98. G. Marchesini, G. Bianchi, and P. Amodio Factors associated with poor health-related quality of life of patients with cirrhosis Gastroenterology 120 2001 170 178
99. G.N. Verne, C. Soldevia-Pico, and M.E. Robinson Autonomic dysfunction and gastroparesis in cirrhosis J Clin Gastroenterol 38 2004 72 76
100. M. Plauth, and E.T. Schutz Cachexia in liver cirrhosis Int J Cardiol 85 2002 83 87
101. F. Strasser, and E.D. Bruera Update on anorexia and cachexia Hematol Oncol Clin North Am 16 2002 589 617
102. G. Marchesini, G. Bianchi, and M. Merli Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial Gastroenterology 124 2003 1792 1801
103. H. Fukushima, Y. Miwa, and E. Ida Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration J Parenter Enteral Nutr 27 2003 315 322